| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.45B | 45.69B | 35.12B | 26.35B | 22.85B | 21.75B |
| Gross Profit | 27.45B | 24.48B | 20.61B | 16.50B | 14.00B | 12.44B |
| EBITDA | 8.36B | 8.76B | 8.17B | 7.77B | 6.52B | 3.33B |
| Net Income | 6.21B | 5.94B | 5.67B | 5.47B | 4.58B | 2.18B |
Balance Sheet | ||||||
| Total Assets | 500.20B | 478.36B | 360.56B | 291.62B | 253.56B | 233.37B |
| Cash, Cash Equivalents and Short-Term Investments | 34.29B | 36.76B | 32.92B | 4.78B | 2.03B | 21.19B |
| Total Debt | 43.27B | 55.46B | 17.57B | 7.83B | 21.16B | 15.79B |
| Total Liabilities | 453.20B | 433.39B | 322.52B | 259.59B | 227.05B | 211.57B |
| Stockholders Equity | 47.00B | 44.98B | 38.04B | 32.04B | 26.51B | 21.80B |
Cash Flow | ||||||
| Free Cash Flow | -13.06B | -126.98B | 5.70B | 21.36B | -9.14B | 13.17B |
| Operating Cash Flow | -12.11B | -123.98B | 6.88B | 22.11B | -8.58B | 13.74B |
| Investing Cash Flow | -5.22B | 19.04B | -55.58B | -7.24B | 1.31B | -12.31B |
| Financing Cash Flow | 15.70B | 109.32B | 61.87B | 30.93B | 16.30B | 6.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹101.78B | 5.96 | ― | 2.15% | 7.08% | 7.69% | |
77 Outperform | ₹99.99B | 6.70 | ― | 1.05% | 8.09% | 2.68% | |
74 Outperform | ₹92.09B | 6.68 | ― | 2.42% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | ₹68.64B | 13.04 | ― | ― | 32.90% | 12.28% | |
56 Neutral | ₹67.65B | 19.93 | ― | 1.63% | 10.02% | -120.18% | |
46 Neutral | ₹114.39B | 13.80 | ― | 2.82% | 6.15% | -64.12% |